Committee Hearings on DOD Anthrax Immunization Program
Chairman Burton held two full Committee hearings in the 106th Congress on the Department of Defense’s Anthrax Vaccine Immunization Program. This program has been fraught with logistical and production problems. Minority views acknowledge the problems with the production and distribution of the vaccine and encourage measures to enhance the protective program. The minority views also note that the Food and Drug Administration testified numerous times that the vaccine is safe and effective for individuals at high risk of exposure to anthrax when used in accordance with the approved labeling.